Get the Stockscreener App
19.13
1.24%
-0.24
Kenvue Inc stock is currently priced at $19.13, with a 24-hour trading volume of 22.54M.
It has seen a -1.24% decreased in the last 24 hours and a -7.14% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $19.45 pivot point. If it approaches the $19.00 support level, significant changes may occur.
Previous Close:
$19.37
Open:
$19.27
24h Volume:
22.54M
Market Cap:
$36.63B
Revenue:
$15.44B
Net Income/Loss:
$1.53B
P/E Ratio:
38.57
EPS:
0.496
Net Cash Flow:
$2.70B
1W Performance:
-0.73%
1M Performance:
-7.14%
6M Performance:
-4.25%
1Y Performance:
+0.00%
1D Range:
$19.11
$19.35
52W Range:
$17.82
$27.80
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
(908) 874-1200
Address
199 Grandview Road, Skillman
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Why Kenvue (KVUE) Could Beat Earnings Estimates Again
Zacks Investment Research
How's AT&T Handling Things?
The Motley Fool
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment Research
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
The Motley Fool
Beyond The Numbers: 5 Analysts Discuss Kenvue Stock
Benzinga
Why 3M Stock Was Moving Higher Today
The Motley Fool
Kenvue Inc Stock (KVUE) Financials Data
Kenvue Inc (KVUE) Revenue 2024
KVUE reported a revenue (TTM) of $15.44 billion for the quarter ending December 31, 2023, a +3.30% rise year-over-year.
Kenvue Inc (KVUE) Net Income 2024
KVUE net income (TTM) was $1.52 billion for the quarter ending December 31, 2023, a -26.65% decrease year-over-year.
Kenvue Inc (KVUE) Cash Flow 2024
KVUE recorded a free cash flow (TTM) of $2.70 billion for the quarter ending December 31, 2023, a +25.53% increase year-over-year.
Kenvue Inc (KVUE) Earnings per Share 2024
KVUE earnings per share (TTM) was $0.8047 for the quarter ending December 31, 2023, a -26.89% decline year-over-year.
Kenvue Inc Stock (KVUE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Xie Bing | Group President APAC |
Feb 13 '24 |
Option Exercise |
0.00 |
4,134 |
0 |
22,746 |
| Lawson Carlton | Group President EMEA & LA |
Feb 13 '24 |
Option Exercise |
0.00 |
4,519 |
0 |
18,280 |
| Mongon Thibaut | Chief Executive Officer |
Feb 13 '24 |
Option Exercise |
0.00 |
8,438 |
0 |
116,522 |
| Howlett Heather | VP & Chief Accounting Officer |
Feb 13 '24 |
Option Exercise |
0.00 |
1,556 |
0 |
1,556 |
| Stevens Meredith | Chief Operations Officer |
Feb 13 '24 |
Option Exercise |
0.00 |
3,215 |
0 |
32,861 |
| Ruh Paul | Chief Financial Officer |
Feb 13 '24 |
Option Exercise |
0.00 |
2,600 |
0 |
27,614 |
| Alvarado Luani | Chief People Officer |
Feb 13 '24 |
Option Exercise |
0.00 |
1,830 |
0 |
15,362 |
| Tillett Caroline | Chief Scientific Officer |
Feb 13 '24 |
Option Exercise |
0.00 |
3,000 |
0 |
21,787 |
| Meurer Jan | Group President, North America |
Feb 13 '24 |
Option Exercise |
0.00 |
2,119 |
0 |
16,782 |
| Orlando Matthew | General Counsel |
Feb 13 '24 |
Option Exercise |
0.00 |
1,371 |
0 |
11,632 |
About Kenvue Inc
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products primarily under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products primarily under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby care, women's health, and wound care products primarily under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
1.28%
1.09%
Cap:
|
Volume (24h):